The Advisory Board Company  

(Public, NASDAQ:ABCO)   Watch this stock  
Find more results for ABCO
-0.05 (-0.11%)
After Hours: 46.57 -0.03 (-0.06%)
Feb 22, 4:11PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 46.38 - 46.85
52 week 18.87 - 51.22
Open 46.55
Vol / Avg. 347,029.00/802,041.00
Mkt cap 1.89B
P/E     -
Div/yield     -
EPS -1.17
Shares 40.15M
Beta 1.15
Inst. own 109%
Feb 21, 2017
Q4 2016 Advisory Board Co Earnings Release (Estimated)
Jan 4, 2017
Advisory Board Co Conference Call to Discuss on the Restructuring Plan in its Health Care
Nov 30, 2016
Advisory Board Co at Piper Jaffray Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 1.40% -14.92%
Operating margin 6.05% -7.08%
EBITD margin - 15.33%
Return on average assets 0.58% -7.38%
Return on average equity 33.59% -31.04%
Employees 3,500 -
CDP Score - -


2445 M St NW
WASHINGTON, DC 20037-1435
United States - Map
+1-202-2665600 (Phone)
+1-202-2665700 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company's healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain. Its higher education programs support colleges and universities in enrollment management; academic programming and student learning; faculty recruitment and retention; student advising and success; alumni affairs and advancement, and college and university operations. The Company offers distinct membership programs, across four areas, which include best practices research and insight, performance technology software, consulting and management services, and data- and tech-enabled services. Its best practices research and insight programs provide the foundation for all of its other programs.

Officers and directors

Robert W. Musslewhite J.D. Chairman of the Board, Chief Executive Officer
Age: 46
Bio & Compensation  - Reuters
David L. Felsenthal President, Director
Age: 45
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael T. Kirshbaum Chief Financial Officer, Treasurer
Age: 39
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Richard A. Schwartz Ph.D. Chief Operating Officer - Health Care
Age: 50
Bio & Compensation  - Reuters
Cormac F. Miller Chief Product Officer
Age: 42
Bio & Compensation  - Reuters
Mary D. Van Hoose Chief Talent Officer
Age: 51
Bio & Compensation  - Reuters
Evan R. Farber Chief Legal Officer and Corporate Secretary
Age: 43
Bio & Compensation  - Reuters
Kelt Kindick Lead Independent Director
Age: 61
Bio & Compensation  - Reuters
Sanjeev K. Bansal Independent Director
Age: 50
Bio & Compensation  - Reuters
Peter J. Grua Independent Director
Age: 62
Bio & Compensation  - Reuters